DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2024Cited by 14
Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic TargetsVindhya Vijay, Nabeel Bardeesy, Lei Shi et al.|Cancer Discovery|2025Cited by 11
SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cellsVanessa S. Silveira, Carlos Alberto Scrideli|Scientific Reports|2020Cited by 5
Data from DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Unknown|2025Cited by 3
Correction: DNAJB1-PRKACA Fusion Drives Fibrolamellar Liver Cancer through Impaired SIK Signaling and CRTC2/p300-Mediated Transcriptional ReprogrammingIlaria Gritti, Nabeel Bardeesy, Jinkai Wan et al.|Cancer Discovery|2025Cited by 0